# Trending Content OS — Daily Run
**Run date:** 2026-09-12

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  active_tools: [google_trends_prefetch, google_news_radar, competitor_list_fallback]
  inactive_tools: [content_database, reddit_live, twitter_live]
  can_run_signal_listener: true
  notes: "site_url not configured — self-check skipped; competitor-list fallback used for dedup/SERP-gap context. Google Trends treated as available via injected SerpAPI pre-fetch block."
next_action: run_signal_listener
```

---

## 2. Google News Radar Coverage Summary

**144 unique headlines across 12 queries** clustered into ~14 topic groups:

| Cluster | Disposition | Rationale |
|---|---|---|
| **FDA egg recall — Salmonella, upgraded to Class I** | **Retained (update)** | New development since 9/8 coverage — highest-risk classification |
| **Sprouts Salmonella outbreak investigation** | **Retained (new)** | Distinct new FDA outbreak notice, not previously covered |
| **FDA Class I device recall** (breathing circuits, catheters, spinal cord stimulators) | **Retained (new)** | High-severity, broad patient impact, thin coverage |
| **CPAP/sleep apnea device recall** (firmware defect) | **Retained (new)** | Sleep-science relevant, Class I severity |
| **Cream cheese / deli salad Listeria recall** | **Retained (new)** | High-risk pathogen, vulnerable-population angle |
| **Atherosclerosis reclassified as autoimmune disease** (Augusta Univ.) | **Retained (new)** | Novel reframing of top chronic disease |
| **Lasker Award — Mignot/narcolepsy** (Stanford) | **Retained (new)** | Tier-1 institutional, durable sleep-science authority piece |
| **Suicide-prevention trial-gap analysis** (CU Anschutz) | **Retained (new)** | Underreported public-health gap, ties to HHS 988 funding news |
| **Psilocybin Phase 2 trial for MDD** (Optimi Health) | **Retained (new, 02b-gated)** | Legitimate trial start, single-source, capped confidence |
| **Stem cell/XPRIZE Healthspan finalist** (Miami) | **Retained (new)** | Aging/longevity milestone, early-stage |
| **AI drug candidate reverses biological age** (Nature phase 2a) | **Rejected — duplicate** | Same story as 9/9 coverage |
| **Presurgical mental-health recovery study** (WashU) | **Rejected — duplicate** | Same story as 9/9 coverage |
| **CDC rabies exposure advisory / AI data-center pollution / wellness darties / HHS 988 funding** | **Rejected — duplicate** | All covered 9/11, no new development |
| **Health-system business/labor news** (Allina strike, Luminis cybersecurity, Atrium exec pay, SSM nurses complaint, Trinity Health layoffs, Arkansas DOH layoffs) | **Rejected — off-category** | Pure labor/business, no patient-health angle |
| **Health insurance coverage-loss policy** (Time) | **Rejected — off-category** | Political/policy framing, not evidence-based health content |
| **Apple Health/fitness AI features** | **Rejected — off-category** | Product announcement, low audience fit |
| **Local wellness fairs/expos & corporate wellness programs** | **Rejected — not actionable / off-category** | Local events or B2B/legal, no national consumer relevance |
| **Dior "Haute Wellness" / Seattle "wellness" scandal** | **Rejected — excluded category** | Beauty marketing / non-health scandal |
| **Clinical-trial trade press** (Rethinking CT grand rounds, Signant Health, Applied CT Q&A, Atlantic/Lilly sponsored, Penn State NIH grant, ALA awareness, Precedence market report, DVIDS, EU newsletter, KevinMD opinion) | **Rejected — off-category/not actionable** | B2B trade press or sponsored content |
| **Dog supplement Salmonella recall** | **Rejected — excluded category** | Pet health |
| **White rice recall / ED drug ingredient recall / seasoning recall / Cyclospora-FDA-inspection follow-up / UVA out-of-body trial / Hofstra, Weill Cornell, USC, MIT academic PR** | **Monitored / deferred** | Lower severity, redundant with retained recall cluster, or insufficient sourcing — see Rejected Log |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-12T00:00:00Z"
  run_completed_at: "2026-09-12T00:00:00Z"
  total_signals_reviewed: 153   # 144 radar + 9 Trends-derived
  total_signals_retained: 10
  total_rejected: 143
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 52
    brand_safety: 3
    duplicate: 6
    weak_signal: 12
    unverified_claim: 3
    other: 67
  highest_priority_topic: "FDA egg recall upgraded to Class I (highest risk)"
  strongest_signal_source: "fda.gov / ABC News"
  tools_unavailable: [reddit_live, twitter_live, content_database]
  notes: >
    Recurring-theme check: "FDA recall" cluster has appeared in 3+ consecutive runs
    (eggs 9/8, blueberries 9/6, cyclospora lettuce 9/6, now eggs-update + sprouts + device
    + cream cheese + CPAP on 9/12) — flag as recurring; recommend a standing "FDA Recall
    Tracker" evergreen format rather than one-off stories per incident going forward.
    No deferred_topics.yaml entries had a passed recheck_on date today.
```

---

## 4. Skill 02b — Health Claim Verification Gate Routing Summary

| Topic | Risk Type | Gate Result | Primary Source | Confidence Cap | Note |
|---|---|---|---|---|---|
| Egg recall (Class I upgrade) | recall | **Pass** | fda_notice | — | Confirmed via FDA classification + ABC News |
| Sprouts Salmonella outbreak | recall | **Pass** | fda_notice | — | Direct FDA outbreak page |
| Device recall (breathing circuits/catheters/spinal stimulators) | recall | **Pass** | fda_notice (via AHA) | — | Trusted secondary names FDA classification directly |
| CPAP/sleep apnea device recall | recall | **Pass** | fda_notice (via Sleep Review) | — | Trusted secondary names FDA classification directly |
| Cream cheese/deli salad Listeria recall | recall | **Pass** | fda_notice (via Newsweek) | — | Trusted secondary names FDA detection directly |
| Atherosclerosis autoimmune reclassification | medical_study | **Pass** | trusted_secondary (univ. press release naming study) | Medium | Single-institution source — flag as not yet independently corroborated |
| Psilocybin Phase 2 trial (MDD) | clinical_trial / drug_or_treatment_claim | **Pass** | manufacturer_statement | Medium | Verify ClinicalTrials.gov registration before publishing |
| Lasker Award (Mignot/narcolepsy) | none | not_applicable | — | — | Award recognition, not a disputed treatment claim |
| Suicide-prevention trial-gap analysis | none | not_applicable | — | — | Meta-analysis of research gaps, not a treatment claim |
| Stem cell/XPRIZE Healthspan finalist | none | not_applicable | — | — | Competition milestone, not an efficacy claim in circulation |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Trend | Opp | Discover | Urgency | Confidence | Content Status |
|---|---|---|---|---|---|---|---|
| **P1** | FDA egg recall upgraded to Class I | 78 | 68 | 4 | today | high | update |
| **P2** | Sprouts Salmonella outbreak investigation | 62 | 70 | 4 | today | medium | new |
| **P2** | FDA Class I device recall (breathing circuits/catheters/spinal stimulators) | 58 | 65 | 3 | today | medium | new |
| **P2** | CPAP/sleep apnea device recall (firmware defect) | 60 | 72 | 4 | today | medium | new |
| **P2** | Cream cheese/deli salad Listeria recall | 60 | 66 | 3 | today | medium | new |
| **P2** | Atherosclerosis reclassified as autoimmune disease | 55 | 74 | 4 | this_week | medium | new |
| **P3** | Too few clinical trials on suicide prevention | 48 | 70 | 4 | this_week | medium | new |
| **P3** | Psilocybin Phase 2 trial for MDD | 52 | 68 | 3 | this_week | medium | new |
| **P3** | Lasker Award — Mignot/narcolepsy discovery | 50 | 62 | 4 | this_week | high | new |
| **P4** | Stem cell therapy — XPRIZE Healthspan finalist | 45 | 60 | 3 | this_week | medium | new |

---

## 6. Editorial Briefs

### P1 — FDA Egg Recall Upgraded to Class I
```yaml
priority_level: P1
publish_timing: immediate
topic: "FDA egg recall upgraded to Class I (highest risk)"
primary_entity: "FDA Salmonella egg recall"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 78
opportunity_score: 68
discover_score: 4
urgency: today
confidence: high
content_status: update
source_count: 3
recommended_angle: "What today's Class I upgrade means for the eggs already recalled — actionable steps for shoppers, tied to the '67% of shoppers avoid a food category' pattern already documented this week."
why_now: "FDA upgraded the ongoing Salmonella egg recall to Class I (highest risk classification) as of 9/11 — a materially new development since initial 9/8 coverage of the outbreak investigation."
primary_headline: "FDA Upgrades Egg Recall to Highest Risk Level as Salmonella Cases Grow"
next_steps: "Full deep-dive brief; verify current lot codes/brand list against FDA notice before publishing; link to prior shopper-avoidance coverage for context."
notes: "⚠️ Integrity note: case counts and lot scope may still be evolving — attribute figures directly to FDA, avoid restating estimates as final."
sources:
  - { publisher: "FDA.gov", url: "https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-sprouts-september-2026", tier: 1, used_for: "reference — confirm separate egg-specific FDA notice URL before publishing" }
  - { publisher: "ABC News", url: "https://abcnews.com/GMA/Food/19-million-eggs-voluntarily-recalled-potential-salmonella-contamination/story?id=135028861", tier: 2, used_for: "Class I upgrade confirmation" }
```

### P2 — Sprouts Salmonella Outbreak Investigation
```yaml
priority_level: P2
publish_timing: short_term
topic: "Salmonella outbreak investigation: sprouts"
primary_entity: "FDA sprouts Salmonella outbreak"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 62
opportunity_score: 70
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Why sprouts remain one of the riskiest raw foods — what the new FDA investigation means for consumers."
why_now: "FDA opened a new Salmonella outbreak investigation tied to sprouts on 9/9, distinct from the egg, blueberry, and cyclospora recalls already covered this week."
primary_headline: "FDA Investigates Salmonella Outbreak Linked to Sprouts"
next_steps: "Full brief; monitor for case-count updates before publish; add general sprout food-safety guidance (USDA)."
notes: "⚠️ Integrity note: investigation is early-stage — scope/case count may expand; avoid definitive causal language."
sources:
  - { publisher: "FDA.gov", url: "https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-sprouts-september-2026", tier: 1, used_for: "Primary outbreak notice" }
```

### P2 — FDA Class I Device Recall (Breathing Circuits, Catheters, Spinal Cord Stimulators)
```yaml
priority_level: P2
publish_timing: short_term
topic: "FDA Class I recall: breathing circuits, catheters, spinal cord stimulators"
primary_entity: "FDA medical device recall"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 58
opportunity_score: 65
discover_score: 3
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Class I medical device recalls hit breathing circuits, catheters, and spinal cord stimulators — what patients and caregivers need to know."
why_now: "FDA issued its highest-severity recall classification across several distinct device categories this week."
primary_headline: "FDA Issues Highest-Level Recall for Breathing Circuits, Catheters, and Spinal Cord Stimulators"
next_steps: "Full brief; break out per-device specifics (separate risk profiles) rather than treating as one uniform recall."
notes: "⚠️ Integrity note: multiple distinct device categories are bundled under one recall action — clarify per-device details before publishing."
sources:
  - { publisher: "American Hospital Association", url: "https://www.aha.org/news/headline/2026-09-08-fda-issues-highest-recall-certain-breathing-circuits-catheters-spinal-cord-stimulators", tier: 2, used_for: "Recall confirmation, FDA classification" }
```

### P2 — CPAP/Sleep Apnea Device Recall (Firmware Defect)
```yaml
priority_level: P2
publish_timing: short_term
topic: "CPAP sleep apnea device recall — Class I, firmware defect"
primary_entity: "FDA CPAP device recall"
signal_type: recall
allowed_category: "sleep science"
trend_strength_score: 60
opportunity_score: 72
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "A firmware defect just triggered a Class I recall for CPAP machines — what sleep apnea patients should do now."
why_now: "FDA classified this CPAP firmware defect recall as Class I (highest risk) this week."
primary_headline: "FDA Issues Class I Recall for CPAP Devices Over Firmware Defect"
next_steps: "Full brief; confirm affected model/serial ranges from FDA database before publishing."
notes: "⚠️ Integrity note: only firmware-affected units are implicated — avoid implying all CPAP devices are recalled."
sources:
  - { publisher: "Sleep Review", url: "https://sleepreviewmag.com/sleep-treatments/therapy-devices/cpap-pap-devices/fda-classifies-sleep-apnea-device-recall-as-class-i-due-to-firmware-defect/", tier: 2, used_for: "Recall confirmation, FDA classification" }
```

### P2 — Cream Cheese & Deli Salad Listeria Recall
```yaml
priority_level: P2
publish_timing: short_term
topic: "Cream cheese and deli salad Listeria recall"
primary_entity: "FDA Listeria recall"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 60
opportunity_score: 66
discover_score: 3
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Listeria in cream cheese and deli salads: who's most at risk and what to check in your fridge."
why_now: "FDA detected Listeria contamination this week, prompting recall of cream cheese and deli salad products."
primary_headline: "Cream Cheese, Deli Salads Recalled After FDA Detects Listeria"
next_steps: "Full brief; lead with pregnant/immunocompromised risk guidance per CDC Listeria protocols."
notes: "⚠️ Integrity note: Listeria carries elevated risk for pregnant people, older adults, and immunocompromised individuals — must be framed specifically, not generalized."
sources:
  - { publisher: "Newsweek", url: "https://www.newsweek.com/cream-cheese-recall-fda-listeria-concerns-12419494", tier: 2, used_for: "Recall confirmation, FDA detection" }
```

### P2 — Atherosclerosis Reclassified as Autoimmune Disease
```yaml
priority_level: P2
publish_timing: short_term
topic: "New study classifies atherosclerosis as an autoimmune disease"
primary_entity: "Atherosclerosis autoimmune reclassification study"
signal_type: study_or_research
allowed_category: "chronic disease management"
trend_strength_score: 55
opportunity_score: 74
discover_score: 4
urgency: this_week
confidence: medium
content_status: new
source_count: 1
recommended_angle: "If heart disease is autoimmune, prevention and treatment approaches could shift — what the new atherosclerosis research means for patients today."
why_now: "A new study reclassifying atherosclerosis as an autoimmune condition could reshape prevention and treatment framing for the leading cause of death in the U.S."
primary_headline: "Study Suggests Atherosclerosis Should Be Classified as an Autoimmune Disease"
next_steps: "Full brief; seek independent cardiologist/immunologist comment before publishing to corroborate single-institution claim."
notes: "⚠️ Integrity note: single-institution press release, not yet independently corroborated by other outlets — present as an emerging hypothesis, not settled consensus; clarify mechanistic vs. causal claims."
sources:
  - { publisher: "Augusta University (Jagwire)", url: "https://jagwire.augusta.edu/new-study-classifies-atherosclerosis-as-an-autoimmune-disease/", tier: 2, used_for: "Primary study announcement" }
```

### P3 — Too Few Clinical Trials on Suicide Prevention
```yaml
priority_level: P3
publish_timing: scheduled
topic: "Analysis: too few clinical trials test suicide-prevention interventions"
primary_entity: "CU Anschutz suicide-prevention trial-gap analysis"
signal_type: study_or_research
allowed_category: "mental health and psychology"
trend_strength_score: 48
opportunity_score: 70
discover_score: 4
urgency: this_week
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Why suicide-prevention research remains dangerously understudied — landing days after HHS's $380M behavioral health investment."
why_now: "New CU Anschutz analysis quantifies the shortage of suicide-prevention clinical trials, adding context to this week's HHS 988 funding news."
primary_headline: "There Aren't Enough Clinical Trials on Suicide Prevention — Here's Why"
next_steps: "Concise brief; must follow safe-messaging guidance (no methods detail, include 988 hotline)."
sources:
  - { publisher: "University of Colorado Anschutz", url: "https://news.cuanschutz.edu/emergency-medicine/stanley-suicide-prevention-study" }
```

### P3 — Psilocybin Phase 2 Trial for Major Depressive Disorder
```yaml
priority_level: P3
publish_timing: scheduled
topic: "Psilocybin-assisted therapy enters Phase 2 trial for MDD"
primary_entity: "Optimi Health psilocybin Phase 2 trial"
signal_type: clinical_trial
allowed_category: "mental health and psychology"
trend_strength_score: 52
opportunity_score: 68
discover_score: 3
urgency: this_week
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Psilocybin therapy for depression just entered Phase 2 trials — what we actually know (and don't) so far."
why_now: "Optimi Health began dosing patients this week in a Phase 2 trial testing psilocybin-assisted therapy for major depressive disorder."
primary_headline: "Psilocybin-Assisted Therapy Enters Phase 2 Trial for Major Depressive Disorder"
next_steps: "Concise brief; verify ClinicalTrials.gov registration before publishing; no efficacy claims — trial just began dosing."
sources:
  - { publisher: "Yahoo Finance", url: "https://finance.yahoo.com/healthcare/articles/optimi-health-initiate-phase-2-124500744.html" }
```

### P3 — Lasker Award: Emmanuel Mignot / Narcolepsy Discovery
```yaml
priority_level: P3
publish_timing: scheduled
topic: "Emmanuel Mignot wins Lasker Award for discovering cause of narcolepsy"
primary_entity: "Emmanuel Mignot"
signal_type: expert_conversation
allowed_category: "sleep science"
trend_strength_score: 50
opportunity_score: 62
discover_score: 4
urgency: this_week
confidence: high
content_status: new
source_count: 1
recommended_angle: "How one scientist's orexin discovery still shapes narcolepsy treatment today."
why_now: "Emmanuel Mignot was just awarded the 2026 Lasker Award for discovering the cause of narcolepsy."
primary_headline: "Narcolepsy Researcher Emmanuel Mignot Wins Prestigious Lasker Award"
next_steps: "Concise brief; strong evergreen/Discover candidate — durable Q&A framing."
sources:
  - { publisher: "Stanford Medicine", url: "https://med.stanford.edu/news/all-news/2026/09/mignot-lasker.html" }
```

### P4 — Stem Cell Therapy / XPRIZE Healthspan Finalist
```yaml
priority_level: P4
publish_timing: evergreen
topic: "Stem cell therapy for aging frailty advances to XPRIZE Healthspan final"
primary_entity: "University of Miami stem cell/XPRIZE Healthspan"
signal_type: data_release
allowed_category: "aging and longevity"
trend_strength_score: 45
opportunity_score: 60
discover_score: 3
urgency: this_week
confidence: medium
content_status: new
source_count: 1
recommended_angle: "A stem cell therapy for aging frailty just became an XPRIZE Healthspan finalist — how close is it to patients?"
why_now: "University of Miami's stem cell therapy advanced to the XPRIZE Healthspan competition final round."
primary_headline: "Stem Cell Therapy for Aging Frailty Advances to XPRIZE Healthspan Final"
next_steps: "Concise brief; clarify this is a competition milestone, not an approved or near-term therapy."
sources:
  - { publisher: "University of Miami Miller School of Medicine", url: "https://news.med.miami.edu/stem-cell-therapy-aging-frailty-xprize-finalist/" }
```

---

## 7. Rejected Topics Log

| Topic/Cluster | Reason |
|---|---|
| HHS $380M behavioral health (988 Day) | duplicate — covered 9/11 |
| CDC rabies exposure advisory | duplicate — covered 9/11 |
| AI data-center pollution health threat | duplicate — covered 9/11 |
| Wellness darties (Gen Z sober parties) | duplicate — covered 9/11 |
| AI drug candidate reverses biological age (Nature phase 2a) | duplicate — covered 9/9 |
| Presurgical mental-health recovery study (WashU) | duplicate — covered 9/9 |
| Health-system business/labor cluster (Allina strike, Luminis cybersecurity, Atrium exec pay, SSM nurses, Trinity layoffs, Arkansas DOH layoffs) | off_category — pure business/labor, no patient-health angle |
| Health insurance coverage-loss (Time) | off_category — political/policy framing |
| Apple Health/fitness AI features | off_category — product announcement, low audience fit |
| Local wellness fairs/expos (Montgomery County, VA Trinka Davis, CSUSM, CSUF) | not_actionable — local events, no national relevance |
| Corporate wellness program regulatory pieces (Ogletree, Holland & Knight) | off_category — B2B/legal |
| Seattle "wellness" supervisor scandal | off_category — not a health topic |
| Dior "Haute Wellness" beauty strategy | brand_safety — beauty/celebrity marketing |
| Santa Barbara Behavioral Wellness Recovery Month PR | not_actionable — local government PR |
| Clinical-trial trade press cluster (Rethinking CT, Signant Health, Applied CT Q&A, Atlantic/Lilly sponsored, Penn State NIH grant, ALA awareness, Precedence market report, DVIDS, EU newsletter, KevinMD opinion) | off_category / not_actionable — trade press or sponsored content |
| Dog supplement Salmonella recall | brand_safety — excluded (pet health) |
| White rice recall (foreign material) | weak_signal — low severity, deferred |
| ED drug ingredient recall (sildenafil/tadalafil) | weak_signal — redundant with retained recall cluster, deferred |
| Seasoning recall (highest FDA risk) | weak_signal — redundant with retained recall cluster, deferred |
| Cyclospora outbreak / declining FDA inspections (PBS) | monitor — valid update angle but deprioritized this cycle due to recall-cluster volume; recheck next run |
| UVA "out-of-body experience" trial | unverified_claim — insufficient primary sourcing/clarity |
| Hofstra, Weill Cornell (spinal stenosis), USC (lung injury), MIT/Protolabs academic PR | not_actionable — narrow academic PR, insufficient national relevance |

---

## 8. Integrity Flags (Consolidated)

⚠️ Egg recall: case counts and lot scope still evolving — attribute directly to FDA.
⚠️ Sprouts outbreak: early-stage investigation — avoid definitive causal claims.
⚠️ Device recall: multiple distinct devices bundled — break out per-device risk.
⚠️ CPAP recall: only firmware-affected units implicated — don't overgeneralize.
⚠️ Listeria recall: elevated risk specifically for pregnant/immunocompromised/older adults — frame precisely.
⚠️ Atherosclerosis study: single-institution source, not independently corroborated — present as emerging hypothesis, distinguish mechanistic claim from clinical consensus.
⚠️ Psilocybin trial: dosing just began — no efficacy data exists yet; verify ClinicalTrials.gov registration before publishing.
⚠️ Suicide-prevention piece: follow safe-messaging guidelines (no methods, include 988).
⚠️ Stem cell/XPRIZE: competition milestone only — not an approved or near-term-available therapy.

---

## 9. Run Notes

- **Recurring theme flag:** "FDA recall" has been a top cluster in 3+ consecutive runs (9/6, 9/7, 9/8, 9/12) — recommend an evergreen "FDA Recall Tracker" format to reduce redundant one-off coverage going forward.
- **site_url not configured** — duplicate/SERP-gap checks relied on competitor-list fallback (`configs/competitor_list.yaml`) rather than a live self-check.
- No `data/deferred_topics.yaml` entries had a passed `recheck_on` date; Cyclospora/FDA-inspection angle and the two deferred minor recalls (ED drug ingredient, seasoning) are recommended additions to deferred topics for a 3-day recheck.
- All required configs loaded successfully; no tool outages beyond the known-inactive optional connectors (Reddit live, Twitter live, content database).